Department of Dermatology, Ruhr-University Bochum, 44791 Bochum, Germany.
Eur J Med Res. 2010 Jan 29;15(1):44-6. doi: 10.1186/2047-783x-15-1-44.
Previous reports on lymphocyte subpopulations in systemic sclerosis (SSc) are conflicting. Therefore, we aimed to investigate the lymphocyte subsets in SSc patients who were not on immunosuppressive therapy.
Lymphocyte subsets were assessed in the peripheral blood of SSc patients (n = 29) and healthy controls (n = 29) using the four colour flow cytometry method. Correlation studies were also performed in order to assess the relationship between lymphocyte subsets and clinical parameters.
The absolute count of lymphocytes (P = 0.0042), CD3+ (P = 0.0014), CD4+ (P = 0.0070), CD8+ (P = 0.021), and CD19+ cells (P = 0.024) was significantly decreased in SSc patients when compared to healthy controls. CD4+/CD8+ ratio and the absolute count of CD56+ cells observed in SSc patients did not significantly differ from controls (P=0.165; P = 0.632, respectively). There was no substantial relationship between the lymphocyte subset levels and clinical features (i.e., SSc subtype, autoantibody profiles, organ involvement), except for a significant inverse correlation of CD19+ cells and the modified Rodnan skin score (r = -0.43, P = 0.020).
Our data support previous reports indicating that subsets of T lymphocytes as well as B lymphocytes play a role in the pathogenesis of SSc.
关于系统性硬化症(SSc)患者淋巴细胞亚群的先前报告存在矛盾。因此,我们旨在研究未接受免疫抑制治疗的 SSc 患者的淋巴细胞亚群。
采用四色流式细胞术方法评估 SSc 患者(n=29)和健康对照者(n=29)的外周血淋巴细胞亚群。还进行了相关性研究,以评估淋巴细胞亚群与临床参数之间的关系。
与健康对照组相比,SSc 患者的淋巴细胞(P=0.0042)、CD3+(P=0.0014)、CD4+(P=0.0070)、CD8+(P=0.021)和 CD19+细胞(P=0.024)的绝对值明显降低。CD4+/CD8+比值和 SSc 患者中观察到的 CD56+细胞的绝对值与对照组无显著差异(P=0.165;P=0.632)。除了 CD19+细胞与改良 Rodnan 皮肤评分呈显著负相关(r=-0.43,P=0.020)外,淋巴细胞亚群水平与临床特征(即 SSc 亚型、自身抗体谱、器官受累)之间没有实质性关系。
我们的数据支持先前的报告,表明 T 淋巴细胞和 B 淋巴细胞亚群在 SSc 的发病机制中起作用。